June 2022
Prof. Hoeller about the potential role for adjuvant therapy in the treatment of intermediate risk melanoma patients
Prof. Dr. Christopher Hoeller, Medical University of Vienna, Vienna, Austria
In this podcast, Prof. Christoph Hoeller will share his view on the potential role for adjuvant therapy in the treatment of intermediate risk melanoma patients.
SUBSCRIBE TO BJMO ONCOTALKS SERIES
